Patient & Survivor Care
From the Journals
All patients with VTE have a high risk of recurrence
Researchers suggest rethinking categorization of patients with incident venous thromboembolism.
Conference Coverage
Minority cancer patient scan discussions 3 minutes shorter
SAN DIEGO - Oncologists spent on average 3 minutes less with minority patients than with nonminority patients discussing a scan result related to...
Conference Coverage
Immunotherapy-related toxicities may be more common than reported in trials
SAN DIEGO – Certain immune-related adverse events related to PD1/PD-L1 treatment of patients with non–small cell...
From the Journals
NHL patients report fear, isolation during chemo
The qualitative study found that patients reported feeling like they were on an “emotional roller coaster” during their treatment.
Conference Coverage
Palliative-rehab combo may improve QoL in newly diagnosed cancer patients
Patients in the rehabilitative palliative care program that included individualized palliative care consultations and a patient/caregiver “school...
Conference Coverage
Refractory immune-mediated colitis: Fecal transplant may be the answer
WASHINGTON – FMT shows promise for the treatment of refractory immune checkpoint inhibitor–associated colitis.
News
FDA approves second pegfilgrastim biosimilar
Pegfilgrastim-cbqv, previously known as CHS-1701, will be marketed as Udenyca by Coherus BioSciences.
From the Journals
Novel risk factors for febrile neutropenia in NHL, solid tumors
Corticosteroid use was most strongly associated with chemotherapy-induced febrile neutropenia.
Hard Questions
Information overload
Once a patient hears “cancer,” they often stop listening. We could go on, spelling out the next steps and treatment options. But patients usually...
Feature
Collaboration is key to bridging the AYA cancer care divide
From the Editor
Pathologic superstition
Without certainty, how can a physician debunk a superstition?